Abhi Chandrasekhara
Senior Associate @ Advantage Capital
New York, United States
Abhi Chandrasekhara is an Investment Professional at Victory Park Capital. He attended The University of Chicago Booth School of Business, University of Maryland - Robert H. Smith School of Business and University of Maryland.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 57%
Last updated:
For AI agents: llms.txt
Industries Abhi Chandrasekhara invests in
Stages Abhi Chandrasekhara invests in
Countries Abhi Chandrasekhara invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Advice 1 (14%)
- Farming 1 (14%)
- Wholesale 1 (14%)
- Consulting 1 (14%)
- Agriculture 1 (14%)
Stage
- Debt Financing 2 (29%)
- Venture - Series Unknown 2 (29%)
- Series C 1 (14%)
- Funding Round 1 (14%)
- Convertible Note 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| GaXtracts is a pharmaceutical ingredients company that manufactures and processes products from industrial hemp.It focuses on the production of CBD and hemp-derived products while producing a medical-grade hand sanitizer since the start of the COVID-19 crisis, helping to fill an urgent market need for hospitals, law enforcement, first responders,and assisted living and home health care businesses. The company partners with farmers, who are experts in cultivation, to purchase their finest organic hemp crops. From there, the company’s pharmaceutical-grade facility takes the plant through an extraction process that removes the CBD molecules and creates a viable essential ingredient for many of today's cutting-edge products.The company is located in Atlanta, Georgia in 2019. | $200K / Venture - Series Unknown / May 18, 2020 | ||
| GaXtracts is a pharmaceutical ingredients company that manufactures and processes products from industrial hemp.It focuses on the production of CBD and hemp-derived products while producing a medical-grade hand sanitizer since the start of the COVID-19 crisis, helping to fill an urgent market need for hospitals, law enforcement, first responders,and assisted living and home health care businesses. The company partners with farmers, who are experts in cultivation, to purchase their finest organic hemp crops. From there, the company’s pharmaceutical-grade facility takes the plant through an extraction process that removes the CBD molecules and creates a viable essential ingredient for many of today's cutting-edge products.The company is located in Atlanta, Georgia in 2019. | $1.8M / Debt Financing / May 18, 2020 | ||
| Cultiva™ has a proprietary technology called SureSeal™ designed to supplement the cuticle of the plant. Our product Parka™ – powered by SureSeal – is now used commercially on multiple high value crops to improve fruit quality and finish, suppress rain cracking, increase marketable yields and prolong shelf life. | $2.9M / Apr 23, 2020 | ||
| Cultiva™ has a proprietary technology called SureSeal™ designed to supplement the cuticle of the plant. Our product Parka™ – powered by SureSeal – is now used commercially on multiple high value crops to improve fruit quality and finish, suppress rain cracking, increase marketable yields and prolong shelf life. | $2.9M / Series C / Apr 23, 2020 | ||
| Danimer Scientific produces a new generation of patented, cost competitive biopolymers. They also offer research, development, and toll manufacturing services for bio-based materials to business partners. They are committed to closed-loop, renewable and sustainable practices, and to products designed to help curb petrochemical plastic pollutionworldwide. Their plant and microbial sourced plastics are biodegradable, durable, and adaptable to a wide range of applications. Their toxin-free manufacturing practices are cost competitive. Their products are FDA approved for food contact, and certified to be aerobically and anaerobically biodegradable or compostable in soil, water, and industrial or home compost by ASTM, OWS, and Vinçotte. | $6.5M / Venture - Series Unknown / Mar 18, 2019 | ||
| Danimer Scientific produces a new generation of patented, cost competitive biopolymers. They also offer research, development, and toll manufacturing services for bio-based materials to business partners. They are committed to closed-loop, renewable and sustainable practices, and to products designed to help curb petrochemical plastic pollutionworldwide. Their plant and microbial sourced plastics are biodegradable, durable, and adaptable to a wide range of applications. Their toxin-free manufacturing practices are cost competitive. Their products are FDA approved for food contact, and certified to be aerobically and anaerobically biodegradable or compostable in soil, water, and industrial or home compost by ASTM, OWS, and Vinçotte. | Debt Financing / Mar 18, 2019 | ||
| Cultiva™ has a proprietary technology called SureSeal™ designed to supplement the cuticle of the plant. Our product Parka™ – powered by SureSeal – is now used commercially on multiple high value crops to improve fruit quality and finish, suppress rain cracking, increase marketable yields and prolong shelf life. | Convertible Note / Mar 01, 2017 |
About Advantage Capital
Advantage Capital has invested over $3.8 billion in more than 800 portfolio companies and projects nationwide since 1992. The firm specializes in growth equity, lending, and mezzanine debt capital investments spanning three distinct but complementary themes, driving local economic development and lasting impact in underserved communities. ____________________ Growing Small Business // 800+ PORTFOLIO COMPANIES // 34 STATES // 66,000+ JOBS SUPPORTED // Small businesses and the entrepreneurs who power them are fundamental to the U.S. economy, driving inclusive economic expansion that allows people and communities to thrive. Advantage Capital offers debt and equity investment opportunities and can provide senior, unitranche and subordinated debt, as well as minority equity financing. The firm invests in companies from a diverse array of industry sectors, including manufacturing, technology and business services, among others. It seeks to make an initial investment between $500K and $10M in companies with $1M+ EBITDA. Financing Affordable Homes // 89 PROJECTS SINCE 2015 // 8,000+ FAMILIES & SENIORS HOUSED // 7 STATES // Creating stronger communities goes beyond business investment and jobs. Financing housing in these same communities creates even more positive and lasting impacts. Expanding Renewable Energy Solutions // $130M IN CAPITAL DEPLOYED // 65 PROJECTS // 20,000+ HOMES POWERED // Increased access to renewable energy supports local green jobs and economic development while building the framework for tomorrow's carbon-free America. ____________________ Geographic Focus: Advantage Capital is committed to impact nationwide, with current emphasis in the following states: Alabama, Arkansas, Connecticut, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Michigan, Mississippi, Missouri, Nebraska, Nevada, New Mexico, Ohio, Pennsylvania, Tennessee, Texas, Utah, Virginia, West Virginia ____________________ Advantage Capital is headquartered in New Orleans, Louisiana and has offices in the following locations: St. Louis, MO; New York, NY; Austin, TX; Hanover, NH; Washington, D.C.; Napa, CA; Nevada.
Advantage Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Greg Hulecki
Venture Partner
|
|||
Gregory Gish
Senior Vice-President
|
|||
Jeffrey Gentsch
Venture Partner
|
|||
Reid Hutchins
Principal
|
|||
Tommy Titus
Vice-President of Business Development
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Abhi Chandrasekhara invest in?
Abhi Chandrasekhara invests primarily in Advice, Farming and Wholesale startups, most often at Debt Financing and Venture - Series Unknown stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Abhi Chandrasekhara?
Public channels for Abhi Chandrasekhara include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Abhi Chandrasekhara last invest?
The most recent investment recorded for Abhi Chandrasekhara closed in May 2020. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
